Clarivate patient centricity report underscores need for evolution from selling products to building relationships

Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of a new report, Walking the talk on patient centricity: An actionable and measurable model for life science companies, which provides analysis of personalised patient engagement and identifies the key pillars of patient centricity.

The report explores how companies can infuse an ethos of patient centricity throughout their operations, measure effective patient centricity, ensure return on investment in patient-centred efforts and identify what a mature patient-centric organisation looks like – with actionable steps that companies can take to build and strengthen their organisations.

A broad trend toward greater patient centeredness has been underway in the healthcare industry for more than a decade, but the COVID-19 pandemic has intensified the urgency of realising this cultural transformation. Successful life science companies are already beginning to build toward a world of personalised medicines. These companies are reorienting their organisations and cultures around patient need, establishing the processes, tools and expertise needed to gather and act upon patient insights and using these insights to generate feedback loops that enhance outcomes and empower patients in their care.

Mike Ward, Global Head of Life Sciences and Healthcare Thought Leadership at Clarivate, said “Alongside the growing trend for precision and personalised medicines it is becoming increasingly apparent that insights from patients can have a positive impact across the whole of the discovery, development and delivery timeline of new treatments. The challenge is how companies can best ensure that those insights are efficiently incorporate into their discovery and development processes.”

While this transition will be a gradual process, life science organisations laying the foundations today stand to realise great value for the patients they serve, as well as their investors. This year’s report finds four pillars of patient centricity which will enable organisations to produce increasingly personalised and targeted drugs and biologics to better defined patient groups.

• Data inputs
• Patient involvement
• A customer experience (CX) approach
• A real-world mindset

The full Patient Centricity Report can be accessed here.

Methodology for the Report

Clarivate contributors analysed multiple data sets and partnered with internal and external subject matter experts, industry executives and patient advocates to provide analysis of patient centricity in the life science industries. Leveraging data and insights from Clarivate patient surveys and studies of the life sciences commercial landscape, the report provides a unified view of the state of patient centricity and company efforts toward greater patient-directedness.

About Clarivate

Clarivate is committed to supporting customers across the entire drug, device and medical technology lifecycles to advance, create and protect innovation. By combining patient journey data, therapeutic area expertise, artificial intelligence and analytics in ways that unlock hidden insights, data-driven decisions and accelerate innovation, Clarivate’s end-to-end research intelligence is designed to enable customers to make informed evidence-based decisions and better understand the changing landscape.